Cisplatin- Versus Carboplatin-Based Chemotherapy in First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: An Individual Patient Data Meta-analysis

Andrea Ardizzoni(University of Bologna), R. Rosell(University of Parma)

JNCI Journal of the National Cancer Institute

June 5, 2007

10.1093/jnci/djk196

Cited by 606

Related Papers

PTEN status in advanced colorectal cancer treated with cetuximab

|British Journal of Cancer|2009|85

Combined use of anti-ErbB monoclonal antibodies and erlotinib enhances antibody-dependent cellular cytotoxicity of wild-type erlotinib-sensitive NSCLC cell lines

|Molecular Cancer|2012|45

Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer

|Cancers|2020|42

Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism

|Oncotarget|2017|35